An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
from https://ift.tt/2CPnsgw
Sem comentários:
Enviar um comentário